28 Oct 2022 , 05:30 PM
Net profit of Dr Reddys Laboratories rose 11.89% to Rs 1114.20 crore in the quarter ended September 2022 as against Rs 995.80 crore during the previous quarter ended September 2021. Sales rose 9.41% to Rs 6305.70 crore in the quarter ended September 2022 as against Rs 5763.20 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 6305.70 | 5763.20 | 9 |
| OPM % | 30.11 | 23.59 | – |
| PBDT | 1922.80 | 1566.60 | 23 |
| PBT | 1613.60 | 1272.50 | 27 |
| NP | 1114.20 | 995.80 | 12 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
